Chris Cirillo

Chris Cirillo has over 20 years of experience in the pharmaceutical industry. Currently, they serve as the Senior Director of Clinical Operations at Chemomab Therapeutics. Prior to this role, they held positions such as Director of Clinical Operations at Chemomab Therapeutics and Associate Director of Clinical Scientist at Adaptimmune. Chris has also worked as a Senior Clinical Project Manager at Gyroscope Therapeutics, a Senior Study Leader (consultant) at Strongbridge Biopharma plc, and a Senior Project Manager (consultant) at The Janssen Pharmaceutical Companies of Johnson & Johnson. Additionally, Chris has held various roles at Pacira BioSciences, Inc., Durata Therapeutics, Mitsubishi Tanabe Pharma America, IKARIA/INO THERAPEUTICS, and PHARMACIA.

Chris Cirillo earned an MBA in Leadership & Entrepreneurialism from Rosemont College in 2012. Prior to that, they obtained a BS in Environmental Science from the University of Delaware in 1996. In 2008, they also obtained the "Competent Communicator" certification from Toastmasters International.